1. Home
  2. TELA vs AYTU Comparison

TELA vs AYTU Comparison

Compare TELA & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

N/A

Current Price

$0.86

Market Cap

31.4M

Sector

Health Care

ML Signal

N/A

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

N/A

Current Price

$1.98

Market Cap

27.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TELA
AYTU
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.4M
27.4M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
TELA
AYTU
Price
$0.86
$1.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$1.90
★ $9.67
AVG Volume (30 Days)
★ 120.6K
19.8K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.59
N/A
EPS
★ N/A
N/A
Revenue
★ $80,275,000.00
$27,632,080.00
Revenue This Year
N/A
$17.96
Revenue Next Year
$8.58
$27.98
P/E Ratio
★ N/A
N/A
Revenue Growth
15.84
★ 277.47
52 Week Low
$0.50
$1.80
52 Week High
$1.50
$3.07

Technical Indicators

Market Signals
Indicator
TELA
AYTU
Relative Strength Index (RSI) 35.73 46.02
Support Level $0.61 $1.94
Resistance Level $0.97 $2.34
Average True Range (ATR) 0.10 0.09
MACD -0.02 0.01
Stochastic Oscillator 0.60 33.33

Price Performance

Historical Comparison
TELA
AYTU

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: